Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia

CD200, formerly known as OX-2, is a type I glycoprotein that is expressed on a variety of cell types. CD200 has been shown to be overexpressed in chronic lymphocytic leukemia (CLL). Although previous studies have confirmed the diagnostic value of CD200 in differentiating CLL from to other B-cell chr...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Yi, Fan, Lei, Wu, Yu-Jie, Xia, Yi, Qiao, Chun, Wang, Yan, Wang, Li, Hong, Min, Zhu, Hua-Yuan, Xu, Wei, Li, Jian-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924660/
https://www.ncbi.nlm.nih.gov/pubmed/26910908
http://dx.doi.org/10.18632/oncotarget.6948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924660/
https://www.ncbi.nlm.nih.gov/pubmed/26910908
http://dx.doi.org/10.18632/oncotarget.6948

Ejemplares similares